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ABSTRACT 
Inhibition Studies of Carbamoyl Phosphate Synthetase from Escherichia coli. 
(December 2005) 
Neha Tripathi, B.S.; M.S., Agra University, India 
Chair of Advisory Committee: Dr. Frank M. Raushel 
Carbamoyl phosphate synthetase (CPS) catalyzes the formation of carbamoyl 
phosphate (CP) from MgATP, bicarbonate, and glutamine. It has three active sites, one 
present on the small subunit and the two phosphorylation sites present on the large 
subunit. These two nucleotide binding sites are homologous. Six compounds were 
designed to mimic the reactive intermediate species carboxy phosphate, and product 
cabamoyl phosphate. The apparent Ki values calculated estimated the inhibitory strengths 
of these compounds. These plots were also utilized in identifying the linear inhibitors, 
nonlinear inhibitors and partial inhibitors. Inhibition patterns were obtained with these 
compounds using various assay formats. Partial inhibition displayed by phosphono 
formate for the full biosynthetic reaction can be utilized in support of the sequential 
mechanism for CPS.  
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CHAPTER I 
INTRODUCTION 
BACKGROUND 
Carbamoyl phosphate synthetase (CPS) catalyzes the formation of carbamoyl 
phosphate (CP), an important intermediate in the arginine and pyrimidine nucleotide 
biosynthetic pathway (1, 3). It belongs to a family of enzymes called amidotransferases, 
like GMP synthetase, anthranilate synthase, imidazole glycerol phosphate synthase etc., 
which have a glutamine utilizing site with conserved cysteine, histidine and glutamate 
residues (2- 4). Ammonia is produced from the amide group of glutamine on the 
amidotransferase domain and subsequently utilized in the synthetase domain. The 
mechanism involves a nucleophilic attack by the thiolate anion of Cys269 on the carbonyl 
carbon of the carboxamide group. There is biochemical and structural evidence for the 
glutamyl thioester intermediate (5). Amidotransferases occur in a variety of pathways for 
biosynthesis of nitrogenous molecules including purine and pyrimidine bases, cofactors, 
aminosugars, amino acids and antibiotics. Thus amidotransferases provide an important 
but not exclusive route of incorporation of nitrogen in these molecules (2). Based on the 
conservation of the glutamine amidotransferase domain, two sub-families of 
amidotransferases, pur F (or F-type) and trp G (or G-type), are recognized. The sub-
family of CPS is trp G (or G-type) amidotransferase because there is homology in the 
amidotransferase domains of CPS and anthranilate synthase, which is coded by the trp G 
gene. Other examples of G-type amidotransferases include aminodeoxychorismate 
synthase, formylglycinamide synthetase, CTP synthetase, GMP synthetase and imidazole 
glycerol phosphate synthase (2, 6). CPS is also a physiologically important enzyme 
because it helps the body get rid of the excess nitrogen by playing an important role in 
the urea cycle of a majority of terrestrial vertebrates (2, 3). 
 X-ray structure of CPS. CPS has been extensively studied for many years but its  
______________ 
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crystal structure was first solved in 1997 (7). The enzyme is an , -heterodimer which 
interconverts easily to an (, )
 4 octamer depending on the presence or absence of 
various effector molecules like ornithine and UMP (3). It consists of two subunits, a 
small glutamine-amidotransferase (GATase) (41,270 Da), encoded by the car A gene. It 
has a total of 382 amino acid residues (2). Hydrolysis of glutamine to form ammonia 
takes place here which is subsequently utilized by the large synthetase subunit (8). 
Mutations to Cys 269 have revealed that this is the residue that confers the enzyme the 
capacity to utilize ammonia (2, 9). The crystal structure revealed that the small subunit is 
bilobal with the C-terminal domain predominantly having a 10-stranded mixed -sheet 
similar to GMP Synthetase. The large synthetase subunit (117,700 Da) is encoded by the 
car B gene. It is composed of a total of 1073 amino acid residues. It houses the other two 
active sites and contains two ATP-grasp motifs (3, 7). The presence of two distinct ATP 
binding sites on the large subunit had earlier been established by steady state kinetics, site 
directed mutagenesis, and inactivation studies using 5’-p-fluorosulfonylbenzoyl 
adenosine (FSBA) (10). The fact that that the enzyme catalyzes two partial reactions also 
point towards catalysis at two ATP site (2). The mutation studies of the residues that are 
near or at the binding sites of the two nucleotide binding sites confirmed the function of 
two homologous halve of the large subunit. N-terminal half was postulated to be the 
bicarbonate phosphorylation site and the C-terminal half was suppose to be the carbamate 
phosphorylation site (11). 
  The crystal structure also revealed the presence of a molecular tunnel ~ 100  
long spanning the entire molecule. The part of the tunnel ~ 45  long that connects the 
first active site to the second active site and is called the ammonia tunnel because it 
transfers ammonia from the small subunit to the phosphorylation site in the large subunit. 
The second half of the tunnel which is ~ 35 connects the second and the third active 
sites and is called the carbamate tunnel because it channels the other reactive species 
carbamate. 
  Substrate channeling is an important feature of amidotransferases. It is thought to 
play an important role in metabolite regulation and cellular modulation of enzymatic 
activities (12).The molecular tunnel protects and channels the reactive intermediates from 
one active site to the next. The tunnel also enhances the catalytic efficiency by preventing 
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1 400 553 933 1073 
Carboxy phosphate  Oligomerization Carbamate Allosteric 
the diffusion of these intermediates into the bulk solvent. Thus substrate channeling is a 
common occurrence in enzymes with multiple catalytic sites (3).  
 Domain organization of CPS. The domain map of CPS is shown in Figure 1.1.  
It shows that the two homologous domains of the large subunit consist of residues 1-400 
and 553-993. There is a 39 % identity and 25 % conservative replacements when two 
halves are compared (8). Residues from 400-553 are involved in the oligomerization of 
the enzyme. The allosteric domain is defined by residues 933-1073. 
 
 
 
 
 
 
 
 
 
 
 Allosteric modulation of CPS. Apart from cradling the two nucleotide binding 
sites, the large subunit of CPS also has the allosteric domain. It is the site where the three 
allosteric effectors UMP, IMP, and ornithine bind (13, 14). CPS is an enzyme that plays a 
key role in the biosynthetic pathways of arginine and pyrimidine nucleotides. Hence 
UMP, which is an end product of the pyrimidine pathway, is a feedback inhibitor of the 
enzyme. Ornithine, however, is an activator of the enzyme whereas IMP can act both as 
an inhibitor or mild activator depending on assay conditions and temperature. UMP and 
the purine nucleotide IMP share the same binding site on the allosteric domain but 
ornithine has a separate binding site. UMP and IMP are competitive with each other 
while ornithine can be bound with either UMP or IMP. The binding sites are present at 
the end of C-terminal domain of the large subunit (14). 
Scheme 1: Domain map of CPS (10). 
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Reactions catalyzed by CPS. For the catalytic reaction, CPS needs two molecules 
of MgATP, HCO3- and glutamine as an ammonia source to form MgADP, inorganic 
phosphate (Pi), and carbamoyl phosphate. The full reaction is given in equation 1. 
 
2MgATP + HCO3- + glutamine + H2O  2MgADP + Pi + glutamate + carbamoyl 
phosphate                                                                                                                (eq.1) 
 
Apart from catalyzing this full reaction, it also catalyzes three partial reactions. These are 
hydrolysis of glutamine, bicarbonate- dependent ATPase reaction, and ATP synthesis 
reaction utilizing ADP and carbamoyl phosphate. These reactions are shown in equations 
2, 3 and 4 (15). In the absence of glutamine or ammonia, the synthesis and breakdown of 
carboxyphosphate is responsible for the ATPase activity of the enzyme (2). 
 
glutamine + H2O    glutamate + NH3                                                               (eq.2) 
MgATP + H2O    MgADP + Pi                                                                        (eq.3) 
MgADP + carbamoyl phosphate    MgATP + NH2CO2 -                                (eq.4) 
 
Kinetic mechanism of CPS. Raushel et al (1978) established the kinetic 
mechanism of the enzyme using initial velocity patterns and product inhibition studies 
(Figure 1.1). For the ammonia-dependent reaction they proposed a Ter-Uni-Uni-Ter 
ordered mechanism. MgATP, HCO3-, and ammonia bind to the active site of the enzyme 
followed by the release of Pi. The second ATP molecule binds before the release of 
MgADP, carbamoyl phosphate and MgADP in that order. When the nitrogen source is 
glutamine, the enzyme follows a two site mechanism in which glutamine binds to the 
small subunit of the enzyme in a random fashion. It is hydrolyzed to glutamate and 
ammonia which is transferred to the large subunit for the synthesis of CP (16). 
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Chemical mechanism of CPS. The mechanism for the Escherichia coli enzyme 
has been established by monitoring the partial reactions, intermediate trapping, and 
positional isotope exchange experiments (17). It involves four partial reactions and three 
reactive intermediates, carboxy phosphate, carbamate and ammonia (Figure 1.2) (18). 
The first intermediate, carboxy phosphate, is formed by phosphorylation of bicarbonate at 
the first ATP-binding site present on the N-terminal half of the large subunit. This is 
followed by a nucleophilic attack on this intermediate by ammonia to form the second 
intermediate, carbamate. At the second ATP-binding site, present on the C-terminal half 
of the large subunit, this intermediate undergoes phosphorylation to form carbamoyl 
phosphate (19). 
 
SPECIFIC AIMS 
Overall goal of this research. The specific aim of this research has been to 
distinguish between the two phosphorylation sites. It has been found that the N- and C-
terminal halves of the large subunit are homologous. This situation has been proposed to 
arise from gene duplication and fusion of an ancestral kinase gene (8). The X-ray crystal 
structure has revealed an ATP-grasp fold present in both domains (7). These structurally 
similar domains phosphorylate bicarbonate and carbamate, but there is still some 
ambiguity regarding the roles of the two nucleotide binding site (10, 20). This research 
aims to develop inhibitors of the substrate, intermediate, and product mimics which can 
MgATP HCO3- NH3  Pi MgATP MgADP Carbamoyl-P MgADP 
Gln Glu 
Figure 1.1: Representation of kinetic mechanism of carbamoyl phosphate (16). 
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Figure1.2: Schematic representation of the mechanism of CPS showing three distinct 
intermediates (21). 
 
 
 
serve as structural probes. Crystal structures complexed with these inhibitors could be 
used to obtain information regarding the binding of bicarbonate, carbamate and 
carbamoyl phosphate to the enzyme. Also any conformational changes which have not 
yet been seen in the enzyme upon binding of the substrate, reactive species and the 
product may be observed in the crystal structures (3). 
Powers Lee and co workers have proposed a parallel or nucleotide switch 
mechanism for CPS. According to this mechanism, synthesis of carbamoyl phosphate 
takes place only within one nucleotide binding domain, carbamate is not transferred via 
the carbamate tunnel to the second phosphorylation site and the conformational changes 
occur at the second nucleotide binding site for which the energy is derived by the 
bicarbonate dependent hydrolysis of MgATP. 
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 Isotopic oxygen exchange of 18O and 16O between the solvent water and [13C] 
bicarbonate in the reaction in the absence of glutamine and no exchange in the presence 
of glutamine indicate that the carbamate actually is used in the synthesis of carbamoyl 
phosphate and is channeled through the tunnel. These results support the sequential 
mechanism of CPS (19). A crystal structure with one of the carbamoyl phosphate analogs 
bound to the C-terminal half of the large subunit would provide support for the actual 
migration of carbamate and further reinforce the sequential mechanism for the enzyme. 
Earlier mutation studies have established residues essential in binding 
bicarbonate, carbamate, and carbamoyl phosphate (10, 22). A crystal structure of the 
enzyme co-crystallized with the inhibitors may enable us to identify residues involved in 
the binding and thus distinguish between the two phosphorylation sites in CPS. The 
kinetic studies with the analogs may be able to provide information about how the highly 
unstable intermediate species carboxy phosphate behaves before it reacts with ammonia 
and also the manner of binding of the second unstable species carbamate at the second 
phosphorylation site. 
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CHAPTER II 
PRELIMINARY INHIBITION EXPERIMENTS WITH CARBOXY PHOSPHATE  
AND CARBAMOYL PHOSPHATE MIMICS 
 Carbamoyl phosphate synthetase is involved in the biosynthesis pathways of 
arginine and pyrimidine nucleotides. It catalyzes the synthesis of carbamoyl phosphate 
from ammonia, bicarbonate and ATP. Structurally it consists of two distinct subunits. 
The small subunit or the GAT domain which is 42,000 Da, produces ammonia from the 
amide of glutamine. The large subunit is 116, 000 Da and the synthesis of carbamoyl 
phosphate from bicarbonate, ammonia and ATP takes place on the C-terminal half of 
CPS. The N-terminal half produces a reactive intermediate carboxyphosphate. Amino 
acid sequence comparison has revealed that the two halves of the large subunit are 
homologous with 39 % identity (8). Despite this similarity the two nucleotide binding 
domains catalyze two different ATP-dependent partial reactions. The N-terminal half is 
responsible for the activation of bicarbonate through an ATP-dependent reaction. The C-
terminal half of the subunit binds the second ATP molecule which phosphorylates 
carbamate leading to the synthesis of carbamoyl phosphate (11). In an attempt to 
distinguish the two nucleotide binding domains of the large subunit, six inhibitors were 
designed. These inhibitors would serve as structural probes of the reactive intermediate 
species carboxy phosphate and final product carbamoyl phosphate. One way of 
distinguishing the N-terminal and the C-terminal halves of the large subunit is by 
obtaining crystal structures complexed with one of these inhibitors. Information 
regarding the behavior of the inhibitor can be obtained from the preliminary experiments. 
 Dixon plots, a plot of 1/v versus inhibitor concentration [I] at some unsaturating 
substrate concentration [S], are employed to identify the type of inhibition and to 
determine the apparent Ki values (23). Preliminary experiments were performed with six 
compounds for three different assay formats. Unsaturating levels of substrates were fixed 
at their Km levels. The structure of the six compounds, which are mimics of carboxy 
phosphate and carbamoyl phosphate are shown in scheme 2. 
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MATERIALS AND METHODS 
Materials. All chemicals and coupling enzymes were purchased from Sigma and 
Aldrich. The inhibitors with the exception of phosphono acetic acid, which was 
purchased from Sigma, were synthesized by Dr. Alona P. Umali (Scheme 2). 
Kinetic measurements. The rate of ADP formation was measured using a pyruvate 
kinase/lactate dehydrogenase coupling system (24). The reaction mixture contained 50 
mM Hepes (pH 7.6), 5 mM MgCl2, 100 mM KCl, 0.5 mM KHCO3, 50 µM ATP, 10 mM 
ornithine, 1.0 mM phosphoenolpyruvate, 0.2 mM NADH, 20 units of pyruvate kinase and 
30 units lactate dehydrogenase. The full reaction was performed using the pyruvate 
kinase/lactate dehydrogenase coupling system but it also contained 1.0 mM glutamine in 
the assay cocktail.  
A hexokinase/glucose-6-phosphate dehydrogenase coupling system was utilized 
to monitor the rate of ATP formation from MgADP and carbamoyl phosphate. The assay 
cocktail contained 50 mM HEPES (pH 7.6), 100 mM KCl, 0.75 mM NAD+, 1.0 mM 
glucose, 22 µM ADP, 2.0 mM carbamoyl phosphate, 20 units of hexokinase, and 10 units 
of glucose-6-phosphate dehydrogenase. The increase in absorbance was monitored at 340 
nm (8, 11). All the assays were run at 25˚C and at pH 7.6. Data were fit to the 
following equations depending on whether the inhibitor was linear or displayed 
cooperative behavior. Data were fit to equation 5 to obtain the Ki values. Data for non-
linear inhibitors were fit to equation 6. Data for phosphono formate were fit to equation 7 
to obtain the Ki and  value.  
v = V / (1 + I / Ki )                                                                                                        (eq.5) 
v = V / (1 + (I / Ki )2)                                                                                                    (eq.6) 
v =  V / (1 + I / Ki)                                                                                                      (eq.7) 
where V is the velocity when inhibitor concentration is zero, v is measured velocity, I is 
the inhibitor concentration, Ki is the inhibition constant and,  is the ratio of the velocities 
when inhibitor concentration is maximum and when inhibitor concentration is zero. 
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Scheme 2: Structures of carboxyphosphate and carbamoyl phosphate inhibitors 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
_______________________________________________________________________ 
In phosphono acetic acid and difluoro phosphono acetic acid, the bridging oxygen of carboxyphosphate has 
been replaced by –CH2 and –CF2 groups respectively. In phosphono formate the bridging oxygen of 
carboxyphosphate is not present. In phosphono acetamide and difluoro phosphono acetamide, the bridging 
oxygen of carbamoyl phosphate has been replaced by –CH2 and -CF2 groups respectively. In phosphono 
formamide O group of carbamoyl phosphate has been omitted. 
_____________________________________________________________________________________ 
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RESULTS 
 Six compounds, which are mimics of carboxy phosphate and carbamoyl 
phosphate, were used as inhibitors of the wild type CPS. The inhibitory effects of these 
surrogates were gauged in preliminary experiments utilizing the two partial reactions and 
the full biosynthetic reaction catalyzed by CPS in the presence of the activator ornithine. 
The units of v and I2 are mOD/min and mM2 respectively. 
 Phosphono acetic acid. The preliminary survey of 1/v versus [I] of phosphono 
acetic acid from the partial forward reaction revealed that this carboxy phosphate analog 
showed linear inhibition. A plot of v versus [I] shown in Figure 2.1 was fit to equation 5. 
When the partial ATP synthesis reaction was monitored using phosphono acetic acid, it 
displayed non-linear inhibition (Figures 2.2 and 2.3). The data for the plot of 1/v versus I2 
were fit was fit to equation 6. It suggests cooperative behavior and binding to more than 
one enzyme form. Preliminary results for the full reaction of CPS with phosphono acetic 
acid are clearly a case of synergism as can be seen from the non-linear plot of 1/v versus 
inhibitor concentration [I] (Figure 2.4). A plot of 1/v versus I2 was fit to equation 6 
(Figure 2.5) 
 Difluoro phosphono acetic acid. For the partial forward reaction, this fluorinated 
carboxy phosphate analog behaved as a linear inhibitor when a plot of 1/v versus [I] was 
examined. A plot of v versus [I] was fit to equation 5 (Figure 2.6). For the partial back  
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reaction, the plot of 1/v versus inhibitor concentration [I] was not linear (Figure 2.7).  
A plot of 1/v versus I2 was fit to equation 6 (Figure 2.8). The results suggests that the 
compound binds to multiple enzyme forms.  For the full reaction, difluoro phosphono 
acetic acid behaved as a linear inhibitor as revealed by observing the data for 1/v versus 
[I]. A plot of v versus [I] was fit to equation 5 (Figure 2.9). 
Phosphono formate. While observing the bicarbonate-dependent ATPase reaction, 
the1/v versus [I] plot showed phosphono formate to be a linear inhibitor. A plot of v 
versus [I] was fit to equation 5 (Figure 2.10). When monitoring the synthesis of ATP, this 
compound behaves as a non-linear inhibitor as seen in Figure 2.11. A plot of 1/v versus I2 
was fit to equation 6 (Figure 2.12). Interestingly for the full biosynthetic reaction this 
compound displayed only partial inhibition. The rate plateaus at a reduced velocity and 
does not reach zero even at a very high inhibitor concentrations. An  value of 0.4 was 
obtained from a fit of the data to equation 7. It is greater than zero is also indicative of 
partial inhibition (Figure 2.13).An initial estimate of the apparent Ki and the  values for 
these analogs with three different assay format are summarized in Table 2.1. These 
values were obtained by fitting the data to equations 5, 6 and 7. 
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Figure 2.1: Plot of v versus [I] with phosphono acetic acid for the partial forward 
reaction from a fit of the data to equation 5. 
 
 
[I] mM
0 10 20 30 40 50 60
v,
 
m
O
D
/m
in
0
5
10
15
20
25
  
14 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2: Plot of 1/v versus [I] with phosphono acetic acid for the partial back reaction. 
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Figure 2.3: Plot of 1/v versus I2 with phosphono acetic acid for the partial back reaction  
from a fit of the data to equation 6. 
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Figure 2.4: Plot of 1/v versus I with phosphono acetic acid for the full biosynthetic 
reaction. 
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Figure 2.5: Plot of 1/v versus I2 with phosphono acetic acid for the full biosynthetic 
reaction from a fit of the data to equation 6. 
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Figure 2.6: Plot of v versus [I] with difluoro phosphono acetic acid for the partial forward 
reaction from a fit of the data to equation 5 
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Figure 2.7: Plot of 1/v versus [I] with difluoro phosphono acetic acid for the partial back 
reaction. 
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Figure 2.8: Plot of 1/v versus I2 with difluoro phosphono acetic acid for the partial back 
reaction from a fit to the data to equation 6. 
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Figure 2.9: Plot of v versus [I] with difluoro phosphono acetic acid for the full 
biosynthetic reaction from a fit of the data to equation 5. 
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Figure 2.10: Plot of v versus [I] with phosphono formate for the partial forward reaction 
from a fit of the data to equation 5. 
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Figure 2.11: Plot of 1/v versus [I] with phosphono formate for the partial back reaction. 
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Figure 2.12: Plot of 1/v versus I2 with phosphono formate for the partial back reaction 
from a fit of the data to equation 6. 
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Figure 2.13: Plot of v versus [I] with phosphono formate for the full biosynthetic reaction 
from a fit of the data to equation 7. 
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Table 2.1: Apparent Ki values for the three carboxy phosphate analogs 
Compounds Reactions [HCO3-] 
mM 
[ATP] 
µM 
[Gln]. 
mM 
[CP] 
mM 
[ADP] 
µM 
Ki 
mM 
 Ki 2 
(mM)2 
 
Partial 
forward 
0.5  50      7.2 ± 
3.0 
 
 
Partial 
back 
   2.0 22   
 
310 ± 
120 
Phosphono 
acetic acid 
Full 0.5  50  1.0     
 
380 ± 
40 
Partial 
forward 
0.5  50     0.7 ± 
0.2 
 
 
Partial 
back 
   2.0  22    700 ± 
80 
Difluoro 
phosphono 
acetic acid 
Full 0.5  50  1.0   1.7 ± 
0.7 
 
 
Partial 
forward 
0.5  50     4.0 ± 
2.0 
 
 
Partial 
back 
   2.0 22    940 ± 
230 
 
Phosphono 
formate 
Full 0.5  50  1.0   0.3 ± 
0 .01 
0.4  
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Phosphono acetamide. For the ATPase assay this carbamoyl phosphate mimcs 
displayed no inhibition as indicated from Figure 2.14. It shows no change in rate on 
increasing the inhibitor concentration. The highest inhibitor concentration used in this 
experiment was 50 mM. For the partial back reaction this carbamoyl phosphate mimic 
behaved as a linear inhibitor when a plot of 1/v versus [I] was examined. A plot of v 
versus [I] is given in Figure 2.15. When observing the hydrolysis of ATP in the presence 
of 1.0 mM glutamine, this compound caused no inhibition as evidenced by no change in 
rate on increasing the inhibitor concentration to 100 mM (Figure 2.16).  
 Difluoro phosphono acetamide. This compound does not inhibit CPS for the 
partial forward reaction. The rate of the enzymatic reaction remained essentially the same 
on increasing the inhibitor concentration as seen in Figure 2.17. The highest 
concentration of inhibitor used in experiment was 50 mM. While observing the partial 
back reaction, this compound behaves as a linear inhibitor. This was based on 
observation of the 1/v versus [I] plot. A plot of v versus [I] is given in Figure 2.18. This 
fluorinated analog of carbamoyl phosphate shows little inhibition for the full reaction, in 
the range of inhibitor concentration (40 mM) used in the experiment as seen in Figure 
2.19.           
 Phosphono formamide. This analog of carbamoyl phosphate does not inhibit the 
partial forward reaction. Almost no change in rate is observed on increasing the inhibitor 
concentration as seen in Figure 2.20. For the partial back reaction, this compound 
behaves as a linear inhibitor. Figure 2.21 shows a plot of v versus [I] which was fit to 
equation 5. When monitoring the full biosynthetic reaction, this compound shows non- 
linear inhibition. Figure 2.22 shows a plot of 1/v versus [I] which clearly shows a non- 
linear trend. On plotting 1/v with a higher power of I (I2) (Figure 2.23), the trend becomes 
linear. A summary of the apparent Ki values obtained by fitting the data to equation 5 and 
7 is given in Table 2.2. 
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Figure 2.14: Plot of v versus [I] with phosphono acetamide for the partial forward 
reaction. 
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Figure 2.15: Plot of v versus [I] with phosphono acetamide for the partial back reaction fit 
of the data to equation 5. 
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Figure 2.16: Plot of v versus [I] with phosphono acetamide for full biosynthetic reaction. 
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Figure 2.17: Plot of v versus [I] with difluoro phosphono acetamide for partial forward 
reaction. 
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Figure 2.18: Plot of v versus [I] with difluoro phosphono acetamide for the partial back 
reaction from a fit of the data to equation 5. 
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Figure 2.19: Plot of v versus [I] with difluoro phosphono acetamide for the full  
biosynthetic reaction. 
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Figure 2.20: Plot of v versus [I] with phosphono formamide for the partial forward 
reaction. 
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Figure 2.21: Plot of v versus [I] with phosphono formamide for the partial back reaction 
from a fit of the data to equation 5. 
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Figure 2.22: Plot of 1/v versus [I] with phosphono formamide for the full biosynthetic 
reaction. 
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Figure 2.23: Plot of 1/v versus I2 with phosphono formamide for the full biosynthetic 
reaction from a fit of the data to equation 6. 
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Table 2.2: Apparent Ki values for the three carbamoyl phosphate analogs 
 
Compounds Reactio
ns 
[HCO3-] 
mM 
[ATP] 
µM 
[Gln]. 
mM 
[CP] 
mM 
[ADP] 
µM 
Ki mM Ki 2 
(mM)2 
 
Partial 
forward 
0.5 50      
Partial 
back 
   2.0 22 
41± 
6.0 
 
Phosphono 
acetamide 
Full 0.5 50 1.0     
Partial 
forward 
0.5 50     
 
Partial 
back 
   2 .0 22 
112 ± 
17 
 
Difluoro 
phosphono 
acetamide 
Full 0.5 50 1.0    
 
Partial 
forward 
0.5 50     
 
Partial 
back 
   2.0 22 
13 ± 
1.0 
 
Phosphono 
formamide 
Full 0.5 50 1.0    
3350±
310 
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DISCUSSION 
Phosphono acetic acid. This compound is a structural mimic of carboxy 
phosphate. When monitoring the partial ATPase assay, it acts as a linear inhibitor for this 
reaction. Since only the N-terminal half of CPS, where the phosphorylation of 
bicarbonate takes place to form carboxy phosphate is involved in this reaction, it can be 
concluded that this mimic competes with bicarbonate and (or) ATP and binds to this 
phosphorylation site. For the partial back reaction which takes place on the second 
phosphorylation site or the C-terminal half of CPS, it is a non-linear inhibitor. It suggests 
that this inhibitor displays synergism and binds to multiple enzyme forms. Two 
molecules of the compound may bind to the phosphorylation site at the N-terminal half of 
the large subunit, one competing with bicarbonate and the other with ATP by virtue of its 
phosphate group or one molecule binding to the N-terminal phosphorylation site and the 
other to some other site other than the active site. In the glutamine-dependent ATPase 
reaction, this compound again displays synergism and binds at multiple sites. This 
compound possibly competes with bicarbonate and (or) ATP at the N-terminal half and 
the second ATP molecule at the C-terminal half of the large subunit.  
 Difluoro phosphono acetic acid.  For the bicarbonate-dependent ATPase assay, 
this compound is a linear inhibitor and thus it can be concluded it binds to the N-terminal 
half of the large subunit where the phosphorylation of bicarbonate takes place to form 
carboxy phosphate, It may compete with bicarbonate and (or ) ATP. While monitoring 
the partial back reaction which gives information about the C-terminal half of the large 
subunit where carbamoyl phosphate is synthesized, this compound acts as a non-linear 
inhibitor. This suggests a cooperative behavior which means that this compound is 
capable of binding to multiple forms of the enzyme. The binding could be at some sites 
other than the active site on the C-terminal half of the large subunit. While observing the 
glutamine-dependent ATPase reaction, difluoro phosphono acetic acid behaved as a 
linear inhibitor, thus suggesting that it binds only at a single nucleotide binding site. 
Since it behaves linearly for the ATPase assay, it means that it binds at the N-terminal 
half of the large subunit where carboxy phosphate is generated. On comparing the 
apparent Ki values of phosphono acetic acid and difluoro acetic acid, it can be concluded 
that the fluorinated analog is a better inhibitor for the partial forward reaction. This could 
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be because of the presence of –CF2 group which is more electronegative than the –CH2 
group and hence serves as a better mimic of the bridging oxygen it is replacing in 
carboxyphosphate (Table 2.1). 
 Phosphono formate. This analog of carboxyphosphate behaves as a linear 
inhibitor suggesting that it binds at one active site. It competes with bicarbonate and (or) 
ATP. For the partial back reaction it displays cooperativity, meaning that it binds at 
multiple enzyme forms. Possibly two molecules bind at sites on the C-terminal half of the 
larges subunit but not necessarily on the active site. Interestingly for the full biosynthetic 
reaction it displays partial inhibition. It has an  value of 0.4. An alpha value of greater 
than zero means that inhibition is partial zero velocity is not possible even at higher 
concentrations of inhibitor. It suggests that the compound binds to one of the two ATP 
binding sites but not preventing the hydrolysis of ATP at the other nucleotide binding site 
leading to the synthesis of carbamoyl phosphate.  
Phosphono acetamide. In the bicarbonate-dependent ATPase reaction this 
carbamoyl phosphate mimic causes negligible inhibition. On increasing the inhibitor 
concentration there is no apparent change in the rate of the enzymatic reaction. As the 
hydrolysis of ATP at the N-terminal half is being monitored in this reaction, it does not 
compete with any of the substrates. This compound does not inhibit the glutamine-
dependent ATPase reaction also. On increasing the inhibitor concentration a negligible 
change in reaction rate is observed. Since it is a carbamoyl phosphate mimic it inhibits 
the partial back reaction in which one of the substrates is carbamoyl phosphate. It linearly 
inhibits the reaction and competes with carbamoyl phosphate and (or) with ADP since it 
also has the PO3- group. Thus it can be concluded that it binds to the phosphorylation site 
on the C-terminal half of the large subunit. 
Difluoro phosphono acetamide. This compound is the fluorinated analog of 
carbamoyl phosphate. For the partial forward reaction it displays no inhibition. No 
decrease in the rate of the reaction is observed on increasing the inhibitor concentration. 
On observation of its inhibitory property in the partial back reaction, it is a linear 
inhibitor competing with carbamoyl phosphate and (or) ADP by virtue of its phosphate 
group. In the full reaction this compound shows negligible inhibition as the inhibitor 
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concentration is increased up to 40 mM. Thus this compound binds only to the 
phosphorylation site at the C-terminal half of the large subunit. 
 Phosphono formamide. This carbamoyl phosphate analog does not inhibit the 
partial forward reaction at the N-terminal half as there is essentially no change in rate on 
increasing the inhibitor concentration (50 mM). Thus no competition with either ATP or 
bicarbonate is observed. For the partial back reaction it binds to the C-terminal half as the 
diagnostic plot for it shows it to be a linear inhibitor. Here it possibly competes with 
carbamoyl phosphate and (or) ADP, for the active site. When monitoring the full 
biosynthetic reaction it is a non-linear inhibitor, which means it displays cooperativity 
and thus binds to multiple enzyme forms. Since this compound does not bind to the N-
terminal half, both the binding sites for the full reaction are likely to be present on the 
large C-terminal half. Therefore two molecules of this compound could bind to the 
phosphorylation site here competing with carbamate and (or) ATP or one molecule could 
bind to the active site and the other to some other site on the enzyme. 
 Based on the preliminary experiments some general trends are observed for the 
acid phosphonates and the amide phosphonates. All three acid phosphonates which serve 
as structural mimics of carboxyphosphate are linear inhibitors of the partial forward 
reaction indicating that they compete with bicarbonate and (or) ATP. Difluoro phosphono 
acetic acid turns out to be the best inhibitor of the three with a Ki value of about 1.0 mM 
which is seven fold less than that of phosphono acetic acid which has a Ki value of 7.2 
mM. Phosphono formate has Ki value of 4.0 mM which is about four fold higher than that 
of Difluoro phosphono acetic acid. This could be because the –CF2 group is more 
electronegative and serves as better mimic of the bridging oxygen, which it replaces in 
carboxyphosphate. 
 In the partial back reaction all the three compounds display synergism which 
indicates that these acid phosphonates bind to more than one site on the C-terminal half 
of the large subunit where the reaction takes place. The binding sites could be, but not 
necessarily be the phosphorylation site. It is also possible that the compound binds to a 
site away from the active site. 
 For the full biosynthetic reaction, these compounds do not follow any general 
pattern and behave in a different manner for the three reactions. Phosphono acetic acid 
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displays cooperative behavior suggesting that it binds to multiple enzyme forms. It is 
possible that this particular compound binds to both the N-terminal and the C-terminal 
halves of the large subunit and. It could compete with bicarbonate and (or) ATP on the 
N-terminal half and also with the second ATP molecule at the C-terminal half. This can 
be said based on Figure 2.3 which does not quite linearize even when an I2 term used. 
Difluoro phosphono acetic acid is a linear inhibitor for this reaction and binds to the 
phosphorylation site on the N-terminal half competing with bicarbonate and (or) ATP. It 
has a Ki value of about 2.0 mM which is two fold higher than its Ki value for the partial 
forward reaction. Phosphono formate shows partial inhibition. This compound binds to 
phosphorylation site on the N-terminal half at the same time not preventing the 
hydrolysis of ATP at the other phosphorylation site indicating that the synthesis of 
carbamoyl phosphate takes place at the C-terminal half and not on the N-terminal half. 
This does not support the nucleotide switch or parallel mechanism by Susan Powers Lee 
which proposes that the full biosynthetic reaction takes place on one single domain which 
alternate with each other (20). It does not have provision for the physical migration of 
carbamate, which is absolutely necessary for carbamoyl phosphate to be formed on the C-
terminal half only. 
 The amide phosphonates which serve as carbamoyl phosphate surrogates do not 
bind at the N-terminal half because they are seen not to inhibit the partial forward 
reaction which takes place on the N-terminal half of the large subunit. This also supports 
the sequential mechanism for the enzyme where carbamoyl phosphate is synthesized 
exclusively on the C-terminal domain by the phosphorylation of carbamate. For the 
partial back reaction these compounds behave as linear inhibitors. Thus carbamoyl 
phosphate mimics bind to the C-terminal half of the large subunit. For the full 
biosynthetic reaction these compounds display little or no inhibition except phosphono 
formamide which displays synergism. The possible binding sites for this compound are 
present on the C-terminal half. One site could be present on the active site where it 
possibly competes with carbamate since its competition with ATP can be ruled out based 
on its behavior in the partial forward reaction. The second molecule may bind to a site  
away from the active site. 
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CHAPTER III 
INHIBITION PATTERNS AND SUMMARY 
Carbamoyl phosphate synthetase catalyzes the assembly of carbamoyl phosphate 
from two molecules of MgATP and a molecule of bicarbonate and glutamine. The 
reaction also produces glutamate, Pi and two molecules of MgADP. It consists of two 
polypeptide chains called the large and the small subunits. The small subunit (42 KDa) is 
known as the amidotransferase domain. It catalyzes the hydrolysis of glutamine to 
ammonia and glutamate which is then transported to the large subunit for the production 
of carbamoyl phosphate. The large subunit (118 KDa) is known as the synthetase 
domain. It can be visualized as two halves having an almost exact 2-fold rotational axis 
(7). This further corroborates the proposal that these two components arise from gene 
duplication and fusion of an ancestral protein (8). Despite the apparent homology in the 
sequences of the two domains of the large subunit, these domains perform two different 
functions. The aim of the inhibition studies is to assess why one domain phosphorylates 
bicarbonate and the other phosphorylates carbamate.    
 Inhibition patterns were obtained for the six carboxy phosphate and carbamoyl 
phosphate analogs were obtained. These compounds were tested for three different assay 
formats, bicarbonate-dependent ATPase glutamine-dependent ATPase, and the partial 
back reaction. For the first two assays, bicarbonate and ATP were the variable substrates. 
When bicarbonate was varied, the ATP concentration was kept constant at its Km value 
(50 µM) and, alternatively, when ATP was varied, the bicarbonate concentration was 
kept constant at its Km value (0.5 mM). For the partial back reaction ADP and carbamoyl 
phosphate were the variable substrates. When carbamoyl phosphate was varied the ADP 
concentration was fixed at 22 µM and when ADP was varied the carbamoyl phosphate 
concentration was kept at 2.0 mM. 
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MATERIALS AND METHODS 
Materials. All chemicals and coupling enzymes were purchased from Sigma and 
Aldrich. The inhibitors except phosphono acetic acid which was purchased from Sigma 
were synthesized by Dr. Alona P. Umali. Their structures are given in Table 2.1. 
Kinetic measurements. The rate of ADP formation was measured using a pyruvate 
kinase/lactate dehydrogenase coupling system (24). The reaction mixture contained 50 
mM Hepes (pH 7.6), 5.0 mM MgCl2, 100 mM KCl, 0.5 mM KHCO3, 10 mM ornithine, 
1.0 mM phosphoenolpyruvate, 0.2 mM NADH, 20 units of pyruvate kinase, 30 units 
lactate dehydrogenase and varying amounts of ATP. When varying amounts of 
bicarbonate were present, the ATP concentration was fixed at 50 µM. The full reaction 
was performed using the pyruvate kinase/lactate dehydrogenase coupling system but it 
also contained 1.0 mM glutamine in the assay cocktail.  
The hexokinase/glucose-6-phosphate dehydrogenase coupling system was utilized 
to monitor the rate of ATP formation from MgADP and carbamoyl phosphate. The assay 
cocktail contained 50 mM HEPES (pH 7.6), 100 mM KCl, 0.75 mM NAD+, 1.0 mM 
glucose, 20 units of hexokinase, and 10 units of glucose-6- phosphate dehydrogenase, 
and variable amounts of ADP and carbamoyl phosphate. The concentration of carbamoyl 
phosphate was fixed at 2.0 mM when ADP was varied and ADP was 22 µM when 
carbamoyl phosphate was varied. The increase in absorbance was monitored at 340 nm 
(8, 11). All the assays were run at 25˚C and at pH 7.6. 
The Kis and Kii values were determined by fitting the experimental data to equations 7-9. 
Equation 7 was for competitive inhibition, equation 8 for uncompetitive inhibition and 
equation 9 for noncompetitive inhibition  
v = (Vm S)/(K(1+I/Kis)+S)                                                                                         (eq.7) 
v = (Vm S)/(K+S(1+I/Kii))                                                                                         (eq.8) 
v = (Vm S)/(K(1+I/Kis))+S(1+I/Kii)                                                                           (eq.9) 
 
In the equations v is the rate, Vm is maximal velocity, S is substrate concentration, 
I is the inhibitor concentration and Kis and Kii are the inhibition constants. 
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RESULTS 
 Phosphono acetic acid. This compound mimics carboxy phosphate which is a 
highly unstable species produced within the N-terminal half of the large subunit. To 
determine how this compound behaves as an inhibitor, the partial forward reaction was 
monitored with variable bicarbonate and ATP. From the inhibition patterns it was evident 
that it is competitive against both bicarbonate and ATP (Figures 3.1 and 3.3). Figure 3.2 
is a fit of the data to the equation 9. On comparing the errors in the Ki values,  values 
and the variance Figure 3.1 was chosen over figure 3.2. The Ki values obtained are 
summarized in Table 3.1. 
 Difluoro phosphono acetic acid. This fluorinated analog competes with 
bicarbonate for the same enzyme form but when ATP was varied it was uncompetitive 
with it for both the partial forward and the full biosynthetic reaction (Figures 3.4, 3.6-
3.8). This observation is consistent with the binding of this compound in a dead-end 
fashion to the E-ATP complex. Figures 3.5 is a fit of the data with difluoro phosphono 
acetic acid for the partial forward reaction against bicarbonate to equation 9 for 
noncompetitive inhibition. Figure 3.9 is a fit of the data for the full biosynthetic equation 
against ATP fit to equation 9 for noncompetitive inhibition. Competitive fit of Figure 3.4 
was chosen over noncompetitive fit of Figure 3.5 and uncompetitive fit of Figure 3.8 over 
noncompetitive fit of Figure 3.9 based on the lower errors in the Ki values,  values and 
the variance.  
 Phosphono formate. This compound behaved as a linear inhibitor for partial 
forward reaction in the preliminary experiment. When the inhibition patterns were 
obtained by varying bicarbonate and ATP, keeping the concentration of the other 
constant, in different experiments, phosphono formate was competitive against 
bicarbonate but noncompetitive against ATP as shown in Figures 3.10 and 3.12. These 
results suggest that the compound can form E.I and E.I.ATP complexes. Phosphono 
formate is competitive with both bicarbonate and ATP (Figures 3.13 and 3.15). This type 
of inhibition is consistent with the formation of an E.I complex that cannot bind either 
ATP or bicarbonate. Figure 3.11, 3.14 and 3.16 are fits of the data of phosphono formate 
for different assay formats to equation 9 for noncompetitive inhibition. The Ki values 
obtained for the carboxyphosphate analogs are summarized in Table 3.1.
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Figure 3.1: Competitive inhibition pattern with phosphono acetic acid against bicarbonate 
for the partial forward reaction from a fit of the data to equation 7. 
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Figure 3.2: Noncompetitive fit with phosphono acetic acid against bicarbonate for the 
partial forward reaction from a fit of the data to equation 9. 
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Figure 3.3: Competitive inhibition pattern with phosphono acetic acid for the partial 
forward reaction with variable ATP from a fit of the data to equation 7. 
  
49 
 
 
 
 
 
 
 
 
 
 
Figure 3.4: Inhibition pattern showing competitive pattern with difluoro phosphono acetic 
acid against bicarbonate for the partial forward reaction from a fit of the data 
to equation 7. 
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Figure 3.5: Inhibition pattern showing noncompetitive pattern with difluoro phosphono 
acetic acid against bicarbonate for the partial forward reaction from a fit of the 
data to equation 9. 
 
 
 
  
51 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6: Uncompetitive inhibition pattern with difluoro phosphono acetic acid against 
ATP for the partial forward reaction from a fit of the data to equation 8. 
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Figure 3.7: Competitive inhibition pattern with difluoro phosphono acetic acid against 
bicarbonate for the full biosynthetic reaction from a fit of the data to equation 
7. 
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Figure 3.8: Uncompetitive inhibition pattern with difluoro phosphono acetic acid against 
ATP for the full biosynthetic reaction from a fit of the data to equation 8. 
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Figure 3.9: Noncompetitive inhibition pattern with difluoro phosphono acetic acid against 
ATP for the full biosynthetic reaction from a fit of the data to equation 9. 
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Figure 3.10: Competitive inhibition pattern with phosphono formate against bicarbonate 
for the partial ATPase reaction from a fit of the data to equation 7. 
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Figure 3.11: Noncompetitive inhibition pattern with phosphono formate against 
bicarbonate for the partial ATPase reaction from a fit of the data to equation 
9. 
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Figure 3.12: Noncompetitive inhibition pattern with phosphono formate against ATP for 
the partial forward reaction from a fit of the data to equation 9. 
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Figure 3.13: Competitive inhibition pattern with phosphono formate against bicarbonate 
for the full biosynthetic reaction from a fit of the data to equation 7. 
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Figure 3.14: Noncompetitive inhibition pattern with phosphono formate against 
bicarbonate for the full biosynthetic reaction from a fit of the data to 
equation 9. 
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Figure 3.15: Competitive inhibition pattern with phosphono formate against ATP for the 
full reaction from a fit of the data to equation 7. 
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Figure 3.16: Noncompetitive inhibition pattern with phosphono formate against ATP for 
the full biosynthetic reaction from a fit of the data to equation 9. 
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Table 3.1: Apparent Ki values of phosphono acetic acid for partial forward reaction and 
difluoro phosphono acetic acid and phosphono formate for partial forward and 
full biosynthetic reaction 
Compound Reaction Variable 
substrate 
Fixed substrate Inhibition 
type 
Kis (mM) Kii (mM) 
HCO3- 50 µM ATP C 4.2 ± 0.8  Phosphono 
acetic acid 
Partial 
forward ATP 0.5 mM HCO3- C 2.0 ± 0.3  
HCO3- 50 µM ATP C 9.3 ± 2.0  Partial 
forward ATP 0.5 mM HCO3- UC  42 ±  5.0 
HCO3- 50 uM ATP C 3.3 ± 0.6  
Difluoro 
phosphono 
acetic acid 
 
Full 
ATP 0.5 mM UC  5.0 ± 0.4 
HCO3- 50 µM ATP C 4.0 ± 0.4  Partial 
forward 
 
ATP 0.5 mM HCO3- NC 8.0 ± 1.4 26 ± 4.3 
HCO3- 50 uM ATP C 5.0 ± 0.7  
Phosphono 
formate 
Full 
ATP 0.5 mM C 6.3 ± 1.2  
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Phosphono acetamide. This carbamoyl phosphate analog inhibits the back 
reaction where carbamoyl phosphate is one of the substrates. It was noncompetitive 
against carbamoyl phosphate but competitive against ADP (Figures 3.17 and 3.18). 
Figure 3.19 is a fit of the data of this compound against ADP fit to equation 9 for 
noncompetitive inhibition. Competitive fit was chosen based on the lower error in the Ki 
value and lower  value and variance.      
 Difluoro phosphono acetamide. This compound has the –CF2 group replacing the 
bridging oxygen in carbamoyl phosphate. On monitoring the back reaction this 
compound turns out to be competitive against both carbamoyl phosphate and ADP 
(Figures 3.20 and 3.22). The data against carbamoyl phosphate seem to indicate 
cooperativity as opposed to the preliminary experiment which indicates that this 
compound is a linear inhibitor. Further experiments need to be done as it is hard to make 
any conclusions based on the experiment. The data against carbamoyl phosphate was also 
fit to equation 9 for noncompetitive inhibition as shown in Figure 3.21. This fit was 
eliminated based on higher errors in the Ki values and higher  and variance. 
 Phosphono formamide. This compound is a mimic of carbamoyl phosphate. 
Partial back reaction which utilizes carbamoyl phosphate and ADP as substrates to 
synthesize ATP, takes place on the C-terminal half of the large subunit of CPS.  Since it 
is structurally close to carbamoyl phosphate it is competitive against it and uncompetitive 
against ADP (Figure 3.23 and 3.25). Figure 3.24 represents the fit of the data against 
carbamoyl phosphate to equation 9 for noncompetitive inhibition. Fit to competitive 
inhibition was chosen based on lower error in the Ki value although fit to noncompetitive 
inhibition shows lower  value and variance. Similarly the data against ADP was also fit 
to noncompetitive inhibition as shown in Figure 3.26. The uncompetitive fit was chosen 
based on the lower errors in Ki values even though it had slightly higher  value and 
variance. Table 3.2 presents the Ki values for the compounds serving as carbamoyl 
phosphate analogs. The unit for 1/a in the plots is 1/ mM and the unit for v is mOD/min. 
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Figure 3.17: Noncompetitive inhibition pattern with phosphono acetamide against 
carbamoyl phosphate for the partial back reaction from a fit of the data to 
equation 9. 
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Figure 3.18: Competitive inhibition pattern with phosphono acetamide against ADP for 
the partial back reaction with from a fit of the data to equation 7. 
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Figure 3.19: Noncompetitive inhibition pattern with phosphono acetamide against ADP 
for back reaction with from a fit of the data to equation 7. 
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Figure 3.20: Competitive inhibition pattern with difluoro phosphono acetamide against 
carbamoyl phosphate for the partial back reaction from a fit of the data to 
equation 7. 
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Figure 3.21: Noncompetitive inhibition pattern with difluoro phosphono acetamide 
against carbamoyl phosphate for the partial back reaction from a fit of the 
data to equation 9. 
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Figure 3.22: Competitive inhibition pattern with difluoro phosphono acetamide against 
ADP for the partial back reaction from a fit of the data to equation 7. 
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Figure 3.23: Competitive inhibition pattern with phosphono formamide against 
carbamoyl phosphate for the partial back reaction from a fit of the data to 
equation 7. 
 
 
 
 
 
  
71 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.24: Noncompetitive inhibition pattern with phosphono formamide against 
carbamoyl phosphate for the partial back reaction from a fit of the data to 
equation 9. 
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Figure 3.25: Uncompetitive inhibition pattern with phosphono formamide against ADP 
for the partial back reaction from a fit of the data to equation 8. 
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Figure 3.26: Noncompetitive inhibition pattern with phosphono formamide against ADP 
for the partial back reaction from a fit of the data to equation 9. 
 
  
74 
 
Table 3.2: Summary of apparent Ki values of phosphono acetamide difluoro phosphono  
acetamide and phosphono formamide for the partial back reaction 
 
Compound Reaction Variable 
substrate 
Fixed 
substrate 
Inhibition 
type 
Kis (mM) Kii (mM) 
CP 22 µM ADP NC 33 ±  9.3 32 ± 6.0  
Phosphono 
acetamide 
Partial back 
ADP 2.0  mM CP C 13 ± 2.3  
CP 22 µM C 15 ± 3.0 
 
Difluoro 
phosphono 
acetamide 
Partial back 
ADP 2.0 mM C 15 ± 3.0 
 
CP 22 µM C 7.0 ± 1.2  Phosphono 
formamide Partial back ADP 2.0 mM UC  7.0 ± 0.4 
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DISCUSSION 
 Bicarbonate- dependent ATPase assay. It is assumed that any changes to this 
assay would report on the part of the large subunit (N-terminal half) where this reaction 
takes place (17). It is within the ATP binding site that phosphorylation of bicarbonate 
takes place and the reactive intermediate species carboxy phosphate is formed. Thus 
phosphono acetic acid is competitive against bicarbonate and ATP with the Kis values of 
4.2 mM and 2.0 mM respectively, when bicarbonate and ATP are varied. The 
competitive behavior against ATP could be due to the presence of the phosphate group on 
the compound. The fluorinated analog of carboxy phosphate, difluoro phosphono acetic 
acid was competitive against bicarbonate and uncompetitive against ATP. The Kii and the 
Kis values are 9.3 mM and 42 mM, respectively. This compound thus competes for the 
same enzyme form with bicarbonate but since it is uncompetitive against ATP, it binds to 
the site available only after ATP is bound. Phosphono formate was competitive against 
bicarbonate and noncompetitive against ATP. This suggests that this compound competes 
with bicarbonate for the same enzyme form but since it is noncompetitive against ATP, it 
suggests that it may also bind to free enzyme to form a E.I. complex, thus causing a 
reduction in the catalytic rate. The three carbamoyl phosphate analogs did not inhibit the 
partial forward reaction so inhibition patterns were not obtained. This is because 
carbamoyl phosphate is utilized in the partial back reaction on the C-terminal half and not 
on the N-terminal half of the large subunit. 
Partial back reaction. It is assumed here also that any inhibition of this reaction 
would shed light on the C-terminal part of the large subunit where it takes place (17). 
Inhibition patterns were obtained for three of the carbamoyl phosphate analogs. 
Phosphono formamide was uncompetitive (Kii 7.0 mM) against ADP and competitive (Kis 
7.0 mM) against carbamoyl phosphate. Competitive behavior suggests that it competes 
for the active site with carbamoyl phosphate but binds to the complex formed by the 
enzyme and ADP. Phosphono acetamide was competitive against ADP and 
noncompetitive against carbamoyl phosphate. This compound competed with ADP for 
the active site but since it showed noncompetitive behavior against carbamoyl phosphate, 
it would also to the ES complex to form the ESI complex. The fluorinated analog of 
carbamoyl phosphate, difluoro phosphono acetamide was competitive inhibition against 
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both carbamoyl phosphate and ADP .This compound would bind with the same enzyme 
form as both carbamoyl phosphate and ADP. 
 Glutamine- dependent ATPase assay. For the full reaction, the fluorinated analog 
of carboxy phosphate, difluoro phosphono acetic acid was competitive against 
bicarbonate and uncompetitive against ATP. Phosphono formate was competitive against 
both bicarbonate and ATP for the full reaction suggesting that this compound binds to the 
same enzyme form as bicarbonate and ATP. 
  
SUMMARY 
 CPS is an enzyme which catalyzes the synthesis of carbamoyl phosphate. It has 
three active sites, one involved with the hydrolysis of glutamine to ammonia and 
glutamate is present on the small subunit and the two nucleotide binding sites where 
phosphorylation of bicarbonate and carbamate takes place to form highly unstable and 
reactive species carboxy phosphate and carbamate. The two domains are thus also known 
as the carboxy phosphate and carbamate domains. These domains are homologous as 
demonstrated by the studies of Nyunoya and Lusty (8), but there certainly is a difference 
in their functions as one phosphorylates bicarbonate and the other carbamate. Mutational 
analysis in the past has helped in identifying residues critical in catalysis but a crystal 
structure with an inhibitor may give further evidence as to the role of these residues. This 
inhibition study aims to differentiate the two phosphorylation sites. 
Preliminary experiments were conducted for the two partial reactions and the full 
reaction with six inhibitors. For the partial forward reaction the two carboxy phosphate 
analogs behaved as linear inhibitors, suggesting that these bind only at one site. Further 
experiments where bicarbonate was varied and ATP was kept constant and when ATP 
was varied with constant bicarbonate concentration, phosphono acetic acid displayed 
competitive inhibition for both the experiments. It indicates that it competes for the active 
site with both ATP and bicarbonate and ATP. The Ki value was more (4.2 mM) when 
bicarbonate was varied than when ATP was varied (2.0 mM). Difluoro phosphono acetic 
acid displayed competitive inhibition when bicarbonate was varied and uncompetitive 
inhibition when ATP was varied. The Ki values were 9.3 mM and 42 mM respectively. 
Phosphono formate which is also a surrogate of carboxyphosphate also showed linear 
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competitive inhibition. Inhibition patterns obtained when bicarbonate and ATP were 
varied indicated that this compound was competitive against bicarbonate but 
noncompetitive against ATP. The other three compounds being analogs of carbamoyl 
phosphate did no inhibit the partial forward reaction. This is indicated by the plots of rate 
versus inhibitor concentration which showed negligible change in rate with increasing 
inhibitor concentration.         
 For the partial back reaction, all the three carboxy phosphate analogs behaved as 
non-linear inhibitors as indicated by the non-linear 1/ v versus inhibitor concentration [I] 
which were parabolic. Information regarding the different binding sites of an enzyme can 
be obtained by this multiple inhibition analysis. These non-linear plots require higher 
powers of [I] to linearize the data suggesting that there are more than two inhibitor 
binding sites (23). Preliminary experiments with the three carbamoyl phosphate analogs 
showed linear inhibition indicating they bind at one site only. Detailed experiments were 
conducted with variable carbamoyl phosphate and fixed ADP and alternatively with 
variable ADP and fixed carbamoyl phosphate. Phosphono formamide which lacks the 
bridging oxygen of carbamoyl phosphate, showed competitive inhibition with a Kis of 7.0 
mM when CP was varied and uncompetitive inhibition with a Kii of 7.0 mM when ADP 
was varied. It indicates that it competes for the same binding spot with carbamoyl 
phosphate due to the structural similarity but not with ADP. When ADP first binds the 
compound binds at a spot in the enzyme other then the active site causing possibly a 
change in the orientation of the active site. Phosphono acetamide was noncompetitive 
when carbamoyl phosphate was varied and competitive inhibition when ADP was varied. 
The fluorinated analog of carbamoyl phosphate, difluoro phosphono formamide showed 
competitive inhibition with both carbamoyl phosphate and ADP.  
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 While observing the full biosynthetic reaction the carboxy phosphate analog 
phosphono acetic acid indicates non-linear inhibition. The fluorinated counterpart, 
difluoro phosphono acetic acid however exhibits linear inhibition. It follows then that 
linear inhibitor binds only at one site while the other binds possibly at multiple binding 
sites. It has Kis and Kii values of 3.3 mM and 5.0 mM when bicarbonate and ATP are 
varied respectively. Partial inhibition was seen when phosphono formate was utilized as 
the structural mimic of carboxyphosphate in the preliminary experiment for the full 
biosynthetic reaction. It was competitive against both bicarbonate and ATP when 
inhibition patterns were obtained. Carbamoyl phosphate mimics phosphono formamide 
was a non-linear inhibitor displaying synergism and so possibly binds to multiple enzyme 
forms. Phosphono acetamide and difluoro phosphono acetamide caused little or 
negligible inhibition to this reaction. 
Results have shown that there are compounds that bind to only C-terminal half of 
the large subunit and some possibly to multiple enzyme forms .Crystal structure of CPS 
complexed with these compounds may help differentiate between the two nucleotide 
binding sites and indicate the mode of binding of bicarbonate, carbamate and carbamoyl 
phosphate. 
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